Baseline survey of the pharmaceutical sector in Tanzania
World Health Organization. (2002). Baseline survey of the pharmaceutical sector in Tanzania. Dodoma, Tanzania : Ministry of Health. http://www.who.int/iris/handle/10665/69110
DescriptionPublished in collaboration with the World Health Organization
MetadataShow full item record
Showing items related by title and MeSH subject.
Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia World Health Assembly, 47 (A47/A/Conf.Paper No.3, 1994)
WHO ethical criteria for medicinal drug promotion: draft resolution proposed by the delegations of Australia, Belgium, Botswana, Cameroon, Canada, Chile, Denmark, Finland, Ghana, Guatemala, Iceland, Kenya, Lesotho，Lithuania, Mexico, New Zealand, Niger, Norway, Spain, Sweden, Switzerland, Thailand, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania and United States of America World Health Assembly, 47 (A47/A/Conf.Paper No.2A47/A/Conf.Paper No.2 Rev.1A47/A/Conf.Paper No.2 Rev.2, 1994)
Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania / Kevin D. Frick ...[et al.] Frick, Kevin D; Lynch, Matthew; West, Sheila; Munoz, Beatriz; Mkocha, Harran A (2003)